Connection

Karel Kostev to Adamantane

Back to Details
This is a "connection" page, showing publications Karel Kostev has written about Adamantane.
Karel Kostev
Connection Strength
0.710
Adamantane
  1. Differences in baseline characteristics between type 2 diabetes mellitus patients treated with dipeptidyl peptidase-4 inhibitors in randomized controlled trials and those receiving the same treatment in real-world settings?. Int J Clin Pharmacol Ther. 2018 Sep; 56(9):411-416.
    View in: PubMed
    Score: 0.710
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.